Price (delayed)
$14.83
Market cap
$47.3M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.17
Enterprise value
$5.94M
vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing oral, small molecule drug candidates. vTv has a pipeline of clinical drug candidates led by programs for the treatment
There are no recent dividends present for VTVT.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.